Retracted: Underlying cardiovascular disease associated with increased mortality in COVID-19 patients
This article has since been retracted by NEJM on 6/11/2020. This 2MM article summary is left unchanged for historical context. ...
This article has since been retracted by NEJM on 6/11/2020. This 2MM article summary is left unchanged for historical context. ...
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial 1. Adults with severe COVID-19 treated with remdesivir ...
1. Use of medications to inhibit the renin-angiotensin system (RAS) following transcatheter aortic valve replacement (TAVR) for severe aortic stenosis ...
1. Black African patients with hypertension randomized to multiple two-drug combinations experienced greater blood pressure control when treated with amlodipine ...
1. Obese trauma patients receiving ACEi/ARB therapy pre-injury had reduced leukocyte inflammatory markers including DL1, CD328, CD154 and CD47 and ...
1. LCZ696 is a novel drug that combines the neprilysin inhibitor, sacubitril, and the angiotensin receptor blocker (ARB), valsartan. 2. ...
Image: PD 1. ACE-Inhibitors were significantly associated with decreased risk of all-cause mortality, cardiovascular death, myocardial infarction, and heart failure ...
Image: PD 1. When compared to a lower dose, high-dose angiotensin-converting-enzyme inhibitor significantly reduced the risk of hospitalization or death ...
1. Benazepril plus amlodipine offers the same effect at reducing blood pressure in hypertensive patients as benazepril plus hydrochlorothiazide. 2. ...
Image: PD 1. Candesartan significantly reduced cardiovascular death and hospital admission for chronic heart failure in patients with heart failure ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.